TIARA TOLBERT: Open Payments
NPI 1518613892 · WINDSOR MILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 21 payments from 8 companies in 2025. Trend: 2023 $334 · 2024 $243 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 6 | $114 |
| Sage Therapeutics, LLC | 4 | $106 |
| Supernus Pharmaceuticals, Inc. | 2 | $52 |
| Evofem Biosciences, Inc. | 2 | $46 |
| Hologic Sales and Service, LLC | 2 | $45 |
| Astellas Pharma US Inc | 1 | $26 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: SLYND, ZURZUVAE, Qelbree, Phexxi, APTIMA, Veozah, GARDASIL 9.
Industry payments across MD — which companies pay providers there.
